Stage II Ovarian Epithelial Cancer
Also known as: Ovarian epithelial cancer stage II / Ovarian cancer stage II
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00112 | Bevacizumab | 1 | Completed | 2 |
| DB00958 | Carboplatin | 1 | Completed | 2 |
| DB01248 | Docetaxel | 1 | Completed | 1 |
| DB06186 | Ipilimumab | 1 | Completed | 1 |
| DB01229 | Paclitaxel | 1 | Completed | 2 |
| DB17459 | Therapeutic allogeneic lymphocytes | 1 | Completed | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB04849 | Cediranib | 2 | Completed | 1 |
| DB01609 | Deferasirox | 2 | Terminated | 1 |
| DB00904 | Ondansetron | 2 | Completed | 1 |
| DB14509 | Lithium carbonate | Not Available | Completed | 1 |
| DB05296 | Motexafin lutetium | Not Available | Terminated | 1 |